Rostra Therapeutics

Private

GlasgowHealthcare & Life Scienceshttps://www.rostratx.com/

Last Round

Grant

Nov 19, 2025

Total Funding Raised

$191,000

Company Overview

Rostra Therapeutics is a biopharmaceutical company that develops novel anti-infective medicines based on its proprietary Strathclyde Minor Groove Binders (S-MGBs) platform to treat serious infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticaldrug discoveryanti-infective medicinesantimicrobial resistanceAMRminor groove bindersS-MGBsinvasive fungal infectionssmall-molecule drugsbiotech startupdrug pipelinepre-clinical developmentuniversity spin-outantibiotic alternatives

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rostra Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Rostra Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Rostra Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Nov 19, 2025
Grant	Nov 13, 2024
Grant	Jun 14, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

David Findlay

Co-founder and CEO

Founding Team

Rostra Therapeutics Investors

Notable investors and investment history

Rostra Therapeutics investors
Investor	Rounds
University of Exeter	Grant
Scottish EDGE	Grant
Cystic Fibrosis Trust	Grant
Medicines Discovery Catapult	Grant
LifeArc	Grant
CF AMR Syndicate	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 3, 2025
Monthly visitors grew 81% MoM, reaching 1.6K.

View all signals

Rostra Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Rostra Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Rostra Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersGlasgow

Employee Range3

Year Founded2022

Last FundingNov 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.